Status | Study |
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
Recruiting |
Study Name: Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma Condition: Carcinoma, Giant Cell Carcinoma, Non-Small-Cell Lung Date: 2007-12-04 |
Active, not recruiting |
Study Name: TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) Condition: Non-Small Cell Lung Cancer Lung Cancer Date: 2007-11-21 Interventions: Drug: Erlotinib 150 mg by mout |